Seroatlas · Human Serome Atlas

RCBTB1

RCC1 and BTB domain-containing protein 1

Also known as: CLLD7, CLLL7, FLJ10716, RCBT1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8NDN9
Gene
RCBTB1
Ensembl
ENSG00000136144
Chromosome
13
Canonical length
531 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

531 residues, UniProt reviewed canonical sequence.

>Q8NDN9|RCBTB1
     1  MVDVGKWPIF TLLSPQEIAS IRKACVFGTS ASEALYVTDN DEVFVFGLNY SNCLGTGDNQ
    61  STLVPKKLEG LCGKKIKSLS YGSGPHVLLS TEDGVVYAWG HNGYSQLGNG TTNQGIAPVQ
   121  VCTNLLIKQV VEVACGSHHS MALAADGEVF AWGYNNCGQV GSGSTANQPT PRKVTNCLHI
   181  KRVVGIACGQ TSSMAVLDNG EVYGWGYNGN GQLGLGNNGN QLTPVRVAAL HSVCVNQIVC
   241  GYAHTLALTD EGLLYAWGAN TYGQLGTGNK NNLLSPAHIM VEKERVVEIA ACHSAHTSAA
   301  KTQGGHVYMW GQCRGQSVIL PHLTHFSCTD DVFACFATPA VSWRLLSVEH EDFLTVAESL
   361  KKEFDSPETA DLKFRIDGKY IHVHKAVLKI RCEHFRSMFQ SYWNEDMKEV IEIDQFSYPV
   421  YRAFLQYLYT DTVDLPPEDA IGLLDLATSY CENRLKKLCQ HIIKRGITVE NAFSLFSAAV
   481  RYDAEDLEEF CFKFCINHLT EVTQTAAFWQ MDGPLLKEFI AKASKCGAFK N

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RCBTB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.23
Highest tissue expression
46 nTPM

Expression across tissuesHPA

Tissue

  • retina: 46 nTPM
  • parathyroid gland: 46 nTPM
  • thyroid gland: 41 nTPM
  • spinal cord: 29 nTPM
  • midbrain: 28 nTPM
  • hippocampal formation: 22 nTPM

Single-cell type

  • cone photoreceptor cells: 147 nCPM
  • rod photoreceptor cells: 125 nCPM
  • oligodendrocyte progenitor cells: 107 nCPM
  • oligodendrocytes: 94 nCPM
  • microglia: 68 nCPM
  • megakaryocyte-erythroid progenitors: 61 nCPM

Immune cell

  • basophil: 17 nTPM
  • T-reg: 9.2 nTPM
  • non-classical monocyte: 8.9 nTPM
  • myeloid DC: 7.6 nTPM
  • intermediate monocyte: 7.4 nTPM
  • eosinophil: 6.5 nTPM

Brain region

  • hypothalamus: 44 nTPM
  • white matter: 44 nTPM
  • basal ganglia: 43 nTPM
  • thalamus: 39 nTPM
  • midbrain: 39 nTPM
  • medulla oblongata: 39 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about RCBTB1.

Disease | AllUniProt

Conditions RCBTB1 is implicated in, by any mechanism.

Disease | GeneticClinVar

34 pathogenic / likely-pathogenic of 448 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.79
gnomAD pLI
0
gnomAD missense Z
1.03
DepMap mean gene effect
0.05
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RCBTB1 as an antibody target. Whether an autoantibody or antibody against RCBTB1 could matter depends on whether native RCBTB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RCBTB1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RCBTB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RCBTB1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...